PT1713805E - Inibidores de quinase - Google Patents

Inibidores de quinase Download PDF

Info

Publication number
PT1713805E
PT1713805E PT05704878T PT05704878T PT1713805E PT 1713805 E PT1713805 E PT 1713805E PT 05704878 T PT05704878 T PT 05704878T PT 05704878 T PT05704878 T PT 05704878T PT 1713805 E PT1713805 E PT 1713805E
Authority
PT
Portugal
Prior art keywords
kinase inhibitors
kinase
inhibitors
Prior art date
Application number
PT05704878T
Other languages
English (en)
Inventor
Chuan Shih
Rosanne Bonjouklian
Mary Margaret Mader
Chafiq Hamdouchi
Alfonso De Dios
Miriam Filadelfa Del Prado
Carlos Jaramillo Aguado
Pramila Kotiyan
Sheila Pleite Selgas
Concepcion Sanchez-Martinez
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34837430&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1713805(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PT1713805E publication Critical patent/PT1713805E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT05704878T 2004-01-30 2005-01-25 Inibidores de quinase PT1713805E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54083004P 2004-01-30 2004-01-30

Publications (1)

Publication Number Publication Date
PT1713805E true PT1713805E (pt) 2009-08-20

Family

ID=34837430

Family Applications (1)

Application Number Title Priority Date Filing Date
PT05704878T PT1713805E (pt) 2004-01-30 2005-01-25 Inibidores de quinase

Country Status (26)

Country Link
US (2) US7582652B2 (pt)
EP (1) EP1713805B1 (pt)
CN (1) CN100516064C (pt)
AR (1) AR047466A1 (pt)
AT (1) ATE433449T1 (pt)
AU (1) AU2005210459B2 (pt)
CA (1) CA2559128C (pt)
CY (1) CY1109234T1 (pt)
DE (1) DE602005014848D1 (pt)
DK (1) DK1713805T3 (pt)
DO (1) DOP2005000010A (pt)
ES (1) ES2326819T3 (pt)
HK (1) HK1100141A1 (pt)
IL (1) IL178103A (pt)
MY (1) MY143516A (pt)
NZ (1) NZ549780A (pt)
PE (1) PE20050689A1 (pt)
PL (1) PL1713805T3 (pt)
PT (1) PT1713805E (pt)
RU (1) RU2348635C2 (pt)
SI (1) SI1713805T1 (pt)
SV (1) SV2006002001A (pt)
TW (1) TWI332003B (pt)
UA (1) UA85505C2 (pt)
WO (1) WO2005075478A1 (pt)
ZA (1) ZA200607648B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI332003B (en) * 2004-01-30 2010-10-21 Lilly Co Eli Kinase inhibitors
US7776869B2 (en) * 2004-10-18 2010-08-17 Amgen Inc. Heteroaryl-substituted alkyne compounds and method of use
EP1992344A1 (en) 2007-05-18 2008-11-19 Institut Curie P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
DK2571878T3 (en) * 2010-05-17 2019-02-11 Indian Incozen Therapeutics Pvt Ltd Hitherto unknown 3,5-DISUBSTITUTED-3H-IMIDAZO [4,5-B] PYRIDINE AND 3,5- DISUBSTITUTED -3H- [1,2,3] TRIAZOL [4,5-B] PYRIDINE COMPOUNDS AS MODULATORS OF PROTEIN CHINES
TWI410425B (zh) * 2010-12-03 2013-10-01 Lilly Co Eli 唑并［５，４－ｂ］吡啶－５－基化合物
MY168927A (en) * 2011-11-11 2019-01-08 Lilly Co Eli Combination therapy for ovarian cancer
IN2015DN00393A (pt) * 2012-07-23 2015-06-19 Univ Akron
TWI731317B (zh) 2013-12-10 2021-06-21 美商健臻公司 原肌球蛋白相關之激酶（ｔｒｋ）抑制劑
EP3233057A2 (en) 2014-12-18 2017-10-25 Genzyme Corporation Pharmaceutical formulations of tropomyosin related kinase (trk) inhibitors
MA41179A (fr) 2014-12-19 2017-10-24 Cancer Research Tech Ltd Composés inhibiteurs de parg
KR20170122799A (ko) * 2015-03-02 2017-11-06 리겔 파마슈티칼스, 인크. TGF-β 억제제
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
PT3691620T (pt) 2017-10-05 2022-10-06 Fulcrum Therapeutics Inc Os inibidores da quinase p38 reduzem a expressão de dux4 e genes a jusante para o tratamento de fshd
US10899869B2 (en) 2019-01-24 2021-01-26 The University Of Akron Glycerol containing polyurethanes and polyurethane nanocomposites
TW202112368A (zh) 2019-06-13 2021-04-01 荷蘭商法西歐知識產權股份有限公司 用於治療有關dux4表現之疾病的抑制劑組合

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL104369A0 (en) * 1992-01-13 1993-05-13 Smithkline Beecham Corp Novel compounds and compositions
DE19503806A1 (de) * 1994-02-11 1995-08-17 Bernhardt Apparatebau Gmbh Co Vorrichtung zum Aufblasen eines Behälters oder eines Schwimmkörpers, insbesondere einer Schwimmweste
US5620999A (en) 1994-07-28 1997-04-15 Weier; Richard M. Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation
US6426360B1 (en) * 1994-07-28 2002-07-30 G D Searle & Co. 4,5-substituted imidazolyl compounds for the treatment of inflammation
US5717100A (en) * 1995-10-06 1998-02-10 Merck & Co., Inc. Substituted imidazoles having anti-cancer and cytokine inhibitory activity
EP0956018A4 (en) * 1996-08-21 2000-01-12 Smithkline Beecham Corp IMIDAZOLE COMPOUNDS, COMPOSITIONS CONTAINING THEM AND THEIR USE
US6087496A (en) * 1998-05-22 2000-07-11 G. D. Searle & Co. Substituted pyrazoles suitable as p38 kinase inhibitors
US6180632B1 (en) * 1997-05-28 2001-01-30 Aventis Pharmaceuticals Products Inc. Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
WO1999000130A1 (en) 1997-06-30 1999-01-07 Temple University - Of The Commonwealth System Of Higher Education Method for treating vulvar vestibulitis
AR016294A1 (es) * 1997-07-02 2001-07-04 Smithkline Beecham Corp Compuesto de imidazol sustituido, composicion farmaceutica que la contiene, su uso en la fabricacion de un medicamento y procedimiento para supreparacion
AR017219A1 (es) * 1997-12-19 2001-08-22 Smithkline Beecham Corp Derivados de imidazol 1,4,5 sustituidos, composiciones que los comprenden, procedimiento para la preparacion de dichos derivados, uso de los derivados parala manufactura de un medicamento
US6207687B1 (en) 1998-07-31 2001-03-27 Merck & Co., Inc. Substituted imidazoles having cytokine inhibitory activity
US6291457B1 (en) 1999-07-01 2001-09-18 Merck & Co., Inc. Compounds having cytokine inhibitory activity
WO2001030778A1 (en) * 1999-10-27 2001-05-03 Novartis Ag Thiazole and imidazo [4,5-b] pyridine compounds and their pharmaceutical use
GB0007405D0 (en) * 2000-03-27 2000-05-17 Smithkline Beecham Corp Compounds
SK10272003A3 (sk) 2001-03-09 2004-07-07 Pfizer Products Inc. Triazolopyrimidýny ako protizápalové činidlá
CN101519386A (zh) 2001-04-16 2009-09-02 田边三菱制药株式会社 高传导率钙-活化k通道开启剂
EP1467981A1 (en) 2002-01-25 2004-10-20 Kylix Pharmaceuticals B.V. 4(hetero-) aryl substituted (thia-/oxa-/pyra) zoles for inhibition of tie-2
ATE323702T1 (de) 2002-08-06 2006-05-15 Astrazeneca Ab Kondensierte pyridine und pyrimidine mit tie2 (tek) aktivität
TWI332003B (en) * 2004-01-30 2010-10-21 Lilly Co Eli Kinase inhibitors

Also Published As

Publication number Publication date
SV2006002001A (es) 2006-02-15
RU2006138606A (ru) 2008-05-10
DK1713805T3 (da) 2009-08-17
CY1109234T1 (el) 2014-07-02
US20090036445A1 (en) 2009-02-05
CN100516064C (zh) 2009-07-22
IL178103A (en) 2011-04-28
US7582652B2 (en) 2009-09-01
DOP2005000010A (es) 2005-11-15
ZA200607648B (en) 2008-06-25
EP1713805A1 (en) 2006-10-25
WO2005075478A1 (en) 2005-08-18
TW200526660A (en) 2005-08-16
AU2005210459A1 (en) 2005-08-18
PE20050689A1 (es) 2005-09-27
AU2005210459B2 (en) 2010-10-21
TWI332003B (en) 2010-10-21
ATE433449T1 (de) 2009-06-15
NZ549780A (en) 2010-01-29
MY143516A (en) 2011-05-31
DE602005014848D1 (de) 2009-07-23
UA85505C2 (en) 2009-01-26
CA2559128A1 (en) 2005-08-18
HK1100141A1 (en) 2007-09-07
PL1713805T3 (pl) 2009-10-30
CA2559128C (en) 2013-04-16
AR047466A1 (es) 2006-01-18
SI1713805T1 (sl) 2009-10-31
CN1938302A (zh) 2007-03-28
RU2348635C2 (ru) 2009-03-10
EP1713805B1 (en) 2009-06-10
US20090318443A1 (en) 2009-12-24
ES2326819T3 (es) 2009-10-20

Similar Documents

Publication Publication Date Title
EP1794137A4 (en) SPECIFIC KINASE INHIBITORS
IL177278A0 (en) Pyrazolotriazines as kinase inhibitors
GB2424882B (en) Selective kinase inhibitors
IL183276A0 (en) Kinase inhibitors
IL190078A0 (en) Kinase inhibitors
EP1761268A4 (en) KINASE INHIBITORS BASED ON PYRROLOTRIAZINE
IL179398A0 (en) Dpp-ib inhibitors
ZA200607648B (en) Kinase inhibitors
HK1114380A1 (en) Pyrrolopyrazoles as kinase inhibitors
EP1773837A4 (en) Pyrrolotriazine KINASE INHIBITORS
IL173381A0 (en) 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors
EP1968950A4 (en) PYRIMIDINKINASEINHIBITOREN
PL1943243T3 (pl) Inhibitory kinazy
HK1090926A1 (en) Pyrazolopyrimidine-derivatives as cyclin dependent kinase inhibitors
ZA200900109B (en) Pyrrolotriazine kinase inhibitors
ZA200709269B (en) Protein kinase inhibitors
EP1778693A4 (en) AS KINASEINHIBITORS USEFUL COMPOUNDS OF TRICYCLIC HETEROARYL
EP1968581A4 (en) TETRACYCLIC KINASE INHIBITORS
SI1896422T1 (sl) Tirosin kinazni inhibitorji
EP1789055A4 (en) INHIBITORS OF THIAZOLOPYRIDINE KINASE
EP1951252A4 (en) INHIBITORS OF TYROSINE KINASES
GB0421355D0 (en) Inhibitors
GB0405985D0 (en) Kinase
IL197981A0 (en) Kinase inhibitors
GB0421356D0 (en) Inhibitors